Sumitomo Mitsui Trust Group Inc. Acquires Shares of 534,803 Medical Properties Trust, Inc. $MPT

Sumitomo Mitsui Trust Group Inc. acquired a new position in shares of Medical Properties Trust, Inc. (NYSE:MPT) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 534,803 shares of the company’s stock, valued at approximately $2,471,000. Sumitomo Mitsui Trust Group Inc. owned about 0.09% of Medical Properties Trust at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in MPT. Asset Management One Co. Ltd. bought a new stake in shares of Medical Properties Trust in the 2nd quarter worth $3,233,000. Diversify Wealth Management LLC bought a new position in shares of Medical Properties Trust during the second quarter valued at about $1,529,000. Resona Asset Management Co. Ltd. bought a new position in shares of Medical Properties Trust during the second quarter valued at about $1,004,000. Oregon Public Employees Retirement Fund purchased a new position in Medical Properties Trust during the second quarter worth about $511,000. Finally, Waterloo Capital L.P. purchased a new position in Medical Properties Trust during the second quarter worth about $466,000. Institutional investors own 71.79% of the company’s stock.

Medical Properties Trust Stock Performance

Shares of NYSE:MPT opened at $4.22 on Friday. The stock has a market cap of $2.52 billion, a P/E ratio of -70.33 and a beta of 1.41. The business has a 50-day moving average of $4.64. The company has a quick ratio of 3.11, a current ratio of 3.11 and a debt-to-equity ratio of 2.13. Medical Properties Trust, Inc. has a fifty-two week low of $3.99 and a fifty-two week high of $6.47.

Medical Properties Trust (NYSE:MPT) last posted its quarterly earnings data on Monday, August 10th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.15. The business had revenue of $259.28 million during the quarter. Medical Properties Trust had a negative net margin of 2.96% and a negative return on equity of 0.66%. The business’s revenue was up 7.9% compared to the same quarter last year. As a group, research analysts predict that Medical Properties Trust, Inc. will post 0.63 earnings per share for the current year.

Medical Properties Trust Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 8th. Stockholders of record on Thursday, September 10th will be given a dividend of $0.09 per share. This represents a $0.36 dividend on an annualized basis and a dividend yield of 8.5%. The ex-dividend date of this dividend is Thursday, September 10th. Medical Properties Trust’s dividend payout ratio is currently -600.00%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on MPT shares. Weiss Ratings downgraded shares of Medical Properties Trust from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Tuesday, August 4th. Royal Bank Of Canada dropped their target price on shares of Medical Properties Trust from $5.00 to $4.50 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average price target of $4.50.

Medical Properties Trust Profile

Medical Properties Trust, Inc (NYSE: MPT) is a real estate investment trust (REIT) that acquires, owns and finances hospitals and other healthcare facilities. Founded in 2003 by Edward K. Aldag Jr., the company’s business model centers on providing real estate capital to healthcare operators through long-term leases, sale-leaseback transactions, build-to-suit developments and mortgage financing. By specializing in healthcare real estate, MPT aims to deliver steady rental income and asset-based returns while enabling operators to access capital for clinical operations and growth.

The company’s portfolio primarily comprises acute care hospitals, inpatient rehabilitation hospitals, long-term acute care facilities, behavioral health centers and other specialty hospitals.